Toronto - Delayed Quote CAD

MediPharm Labs Corp. (LABS.TO)

0.0750 -0.0050 (-6.25%)
At close: August 31 at 3:59:59 p.m. EDT
Chart Range Bar
Loading chart for LABS.TO
  • Previous Close 0.0800
  • Open 0.0800
  • Bid 0.0750 x --
  • Ask 0.0800 x --
  • Day's Range 0.0750 - 0.0800
  • 52 Week Range 0.0600 - 0.1000
  • Volume 45,405
  • Avg. Volume 173,673
  • Market Cap (intraday) 32.038M
  • Beta (5Y Monthly) 0.93
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.

www.medipharmlabs.com

127

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Performance Overview

Trailing total returns as of 2026-08-31, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

LABS.TO
7.14%
S&P/TSX Composite index (^GSPTSE)
13.82%

1-Year Return

LABS.TO
6.25%
S&P/TSX Composite index (^GSPTSE)
26.98%

3-Year Return

LABS.TO
11.76%
S&P/TSX Composite index (^GSPTSE)
78.74%

5-Year Return

LABS.TO
77.94%
S&P/TSX Composite index (^GSPTSE)
76.22%

Earnings Trends

View More

Earnings Per Share (GAAP)

 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 8.96M
Earnings -867k
Profit Margin -9.67%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
5M
10M
-30.0%
-25.0%
-20.0%
-15.0%
-10.0%
 

Statistics

View More

Valuation Measures

Annual
As of 2026-08-27
  • Market Cap

    34.17M

  • Enterprise Value

    24.75M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.82

  • Price/Book (mrq)

    0.96

  • Enterprise Value/Revenue

    0.60

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -12.00%

  • Return on Assets (ttm)

    -5.17%

  • Return on Equity (ttm)

    -13.22%

  • Revenue (ttm)

    41.46M

  • Net Income Avi to Common (ttm)

    -4.97M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.42M

  • Total Debt/Equity (mrq)

    1.19%

  • Levered Free Cash Flow (ttm)

    2.06M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch